If you have ADHD and you are entering addiction treatment, one of the first questions you are probably asking is whether you have to stop your medication. It is a fair question, and the answer is more nuanced than a simple yes or no.
It depends on what you are taking, what you are being treated for, and the clinical judgment of the team managing your care. Here is what you need to know.
Why ADHD and Addiction Go Together So Often
Adults with ADHD are much more likely to develop substance use disorders than the general population, and the relationship runs in both directions [1]. Untreated ADHD creates conditions where drugs and alcohol become a way of coping with symptoms like impulsivity, emotional dysregulation, and the inability to slow a brain that will not stop running.
Treating the addiction without addressing the underlying ADHD is treating only part of the picture.
The Problem With Stimulant Medications in Early Recovery
Most first-line ADHD medications, including Adderall, Vyvanse, and Ritalin, are stimulants. They work by increasing dopamine and norepinephrine in the brain, which makes them effective for ADHD but also complicated in addiction treatment.
For someone in early recovery who used stimulants, alcohol, or other substances that affect the brain’s reward system, introducing or continuing a stimulant as a medication requires careful clinical evaluation. The timing, dosing, and clinical context all matter significantly [2].
Most residential programs, including abstinence-based programs, approach stimulant ADHD medications with caution in the early weeks of treatment. Some pause them temporarily. Others evaluate whether a non-stimulant alternative is a better fit for the duration of residential care. The decision is made individually, not by a blanket policy.
Non-Stimulant Options That Work in Treatment Settings
The good news is that stimulants are not the only option. Non-stimulant ADHD medications have no abuse potential and do not carry the same clinical concerns in addiction treatment settings [3].
Two of the most commonly used non-stimulant options for ADHD include:
- Atomoxetine (Strattera): The first non-stimulant FDA-approved specifically for ADHD, it works by targeting norepinephrine rather than dopamine and carries no risk of dependence or misuse [4].
- Bupropion (Wellbutrin): An antidepressant with demonstrated benefit for ADHD symptoms, particularly useful when depression or anxiety are also present, and sometimes used in alcohol use disorder treatment as well.
For many people in residential treatment, a non-stimulant option provides enough symptom management to get through the early weeks of recovery.
What Happens to Your ADHD Symptoms in Early Recovery?
During the early weeks of sobriety, especially if you are not taking your regular stimulant medications, it can be harder to focus, organize, and plan tasks. The brain is recalibrating its dopamine reward system, and the process to shift back to a balanced state takes some time.
This period can feel disorienting with brain fog, increased exhaustion, and intense mood swings. Clinical support during early recovery matters: medical professionals address the symptoms as they appear not only to increase comfort but also reduce the risk of relapse.
What Does Stimulant Care Look Like at Rushton?
At Rushton Recovery, our medical team conducts a comprehensive psychiatric evaluation at intake that includes a thorough review of any existing diagnoses and medications. If you arrive with an ADHD diagnosis and a current stimulant prescription, that medication is reviewed as part of your overall clinical picture, not automatically discontinued and not automatically continued without evaluation.
For some clients, a temporary switch to a non-stimulant medication during residential treatment is the right call. For others, a stimulant medication remains part of their care — with careful monitoring and clinical justification. Our medical team builds that decision on your history, current symptoms, and what is clinically safest for you.
Questions to Ask Before You Arrive
If you have ADHD and are entering treatment, these are worth raising with the admissions or clinical team:
- Does the program evaluate ADHD diagnoses at intake?
- Is medication management available on-site, and who manages it?
- What is the program’s policy on stimulant medications during residential treatment?
- Are non-stimulant alternatives available if a switch is recommended?
ADHD and Addiction Treatment at Rushton Recovery
Rushton Recovery is a private, medically supervised detox and residential program on 30 acres in South Lyon, Michigan, near Ann Arbor. Our medical team, led by Dr. Khatiwala, includes psychiatric nurse practitioners and clinical staff experienced in co-occurring conditions such as ADHD alongside addiction.
We accept Blue Cross Blue Shield and Blue Care Network as in-network carriers and work with most major insurance plans, including Aetna, Cigna, Humana, UnitedHealthcare, Anthem, Carelon, and Magellan. Our admissions team verifies your benefits the same day you reach out.
If you have questions about how your ADHD diagnosis will be managed during treatment, that conversation starts with one call.
Sources:
[1] National Institute on Drug Abuse. (2024). Misuse of ADHD prescription stimulants in adults. NIH National Library of Medicine.
[2] Caci, H., et al. (2023). Challenges of treating ADHD with comorbid substance use disorder: Considerations for the clinician. Journal of Clinical Medicine, 12(9), 3096.
[3] Brancati, G. E., et al. (2024). Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder. Expert Opinion on Pharmacotherapy.
[4] Kratochvil, C. J., et al. (2004). Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Pediatric Drugs.